| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
5 companies
Invus Public Equities, L.P. last filed a Form 4 in December 2024, as Director, 10% Owner at LXRX. The filings on record cover 5 companies. From November 2017 to December 2024, the filings on record show 22 open-market purchases and 8 sales.
Our model assigns Invus Public Equities, L.P. a strong insider score of 78/100, based on 26 past trades. Over a 12-month horizon, 80.8% of those trades were profitable, with an average 12-month return of +40.5%.
At the last filing, the largest reported position was 9,250,005 shares of SRRK. Net of sales, the SRRK filings show accumulation of 499,971 shares.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | CBIO Crescent Biopharma, Inc. | 10% Owner | Buy | 1,515,266 | $2.00 | $3,027,928.63 | +23.1% | +4.0% | +71.3% | |
| Feb 9, 2023 | CBIO Crescent Biopharma, Inc. | 10% Owner | Buy | 11,451 | $3.24 | $37,123.00 | +0.2% | -46.0% | +0.9% | |
| Jan 9, 2023 | SRRK Scholar Rock Holding Corp | 10% Owner | Sell | 1,094 | $9.48 | $10,373.31 | - | -15.3% | +71.2% | |
| Jan 5, 2023 | SRRK Scholar Rock Holding Corp | 10% Owner | Buy | 48,774 | $9.33 | $455,090.68 | +0.5% | -18.6% | +71.7% | |
| Oct 25, 2022 | SRRK Scholar Rock Holding Corp | 10% Owner | Buy | 130,265 | $8.04 | $1,047,382.71 | +1.5% | +46.8% | +11.4% | |
| Oct 4, 2022 | SRRK Scholar Rock Holding Corp | 10% Owner | Buy | 99,971 | $7.60 | $759,548.75 | +1.1% | +20.2% | -15.1% | |
| Feb 1, 2021 | SEER Seer, Inc. | 10% Owner | Sell | 252,545 | $64.15 | $16,201,519.39 | -4.3% | - | - | |
| Dec 16, 2020 | LXRX Lexicon Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 10,937,500 | $3.20 | $35,000,000.00 | +51.3% | - | - | |
| Dec 8, 2020 | SEER Seer, Inc. | 10% Owner | Buy | 790,000 | $19.00 | $15,010,000.00 | +15.6% | - | - | |
| Jun 16, 2020 | GBIO Generation Bio Co. | 10% Owner | Buy | 800,000 | $19.00 | $15,200,000.00 | +39.7% | - | - |